Medical Fluid Identification via Tracer Compound Sensors

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medical injection systems lack effective methods for identifying and validating medical fluids before, during, and after injection, particularly in distinguishing between clear fluids and detecting air bubbles or improper storage of contrast media, which can lead to harmful errors.

Innovation Solution

Incorporating a system with a fluid containing an active compound and a tracer compound, such as nanoparticles or fluorescent nanocrystals, that allows for real-time measurement and adjustment of injection parameters using sensors and feedback paths to ensure accurate fluid delivery and detection of properties like flow rate, extravasation, and concentration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If manual syringe injection is used, then operator feedback on fluid pressure/flow is provided, but operator fatigue occurs and fluid pressure/flow varies depending on operator strength

Engineering Contradiction:
Improveoperator feedbackVSAvoidfluid pressure consistency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system uses sensors to automatically monitor fluid pressure, flow rate, and injection parameters without requiring continuous operator intervention. The feedback loop self-adjusts injection parameters based on real-time measurements, eliminating operator fatigue while maintaining consistent fluid delivery.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent implements electronic feedback loops where sensors continuously measure injection parameters and provide real-time data to the control system. This automated feedback replaces manual operator feedback, ensuring consistent fluid pressure and flow rate without operator fatigue.

Inventive Principle:
Principle #23Feedback

2Ease of operation

If powered injector automation is used, then operator effort is reduced, but interactive control between operator and injector is eliminated except for start/stop

Engineering Contradiction:
Improveoperator effortVSAvoidinteractive control
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The system dynamically adjusts injection parameters in real-time based on sensor feedback while allowing operator intervention when needed. The control system transitions between fully automated operation and operator-controlled modes, providing both reduced effort and maintained adaptability.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

Real-time sensor feedback enables the powered injector to automatically adjust injection parameters while still allowing the operator to intervene and modify settings when clinical conditions require adaptive control.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If clear pharmaceutical contrast is used, then it can be detected by sophisticated imaging systems, but it is difficult to distinguish from air bubbles by eye

Engineering Contradiction:
Improveimaging detectionVSAvoidvisual identification
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent incorporates colorimetric indicators or fluorescent tracers in the contrast media that change color or emit light under specific conditions. This allows visual differentiation between clear contrast and air bubbles while maintaining detectability by imaging systems.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The system uses optical sensors or imaging detectors as intermediaries to identify and distinguish clear contrast media from air bubbles, providing visual feedback to the operator without compromising the contrast's effectiveness in medical imaging.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Measurement precision

If tracer compounds are added to fluid, then real-time measurement and monitoring is enabled, but fluid composition complexity increases

Engineering Contradiction:
Improvereal-time monitoringVSAvoidfluid composition
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses tracer compounds that alter measurable physical or chemical parameters of the fluid (such as optical properties, conductivity, or magnetic characteristics). These parameter changes enable real-time monitoring without significantly complicating the overall fluid composition or requiring complex additional components.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the safety and accuracy of medical fluid injections by enabling real-time monitoring and adjustment, reducing the risk of air bubbles and improper fluid administration, and ensuring the correct concentration and properties of contrast media are maintained.

Implementation Method 1

fluid having at least one active compound and at least one tracer compound... at least one sensor is configured to measure at least one property of the at least one tracer compound in the fluid

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

the at least one tracer compound may comprise at least one up-converting fluorescent nanocrystal

Methodology Applied
Scientific EffectUp-converting fluorescent nanocrystal emission:

Data Source

PatentUS11083836B2System and method for medical fluid identification and verification
Publication Date: 2021.08.10 BAYER HEALTHCARE LLC
  • US11083836B2 patent drawing
  • US11083836B2 patent drawing
  • US11083836B2 patent drawing

AI summary

A system for injecting fluid to a patient is provided. The system provides manual or automatic verification and identification of the fluid to be injected, prior to, during or after injection. The system includes: a fluid having at least one active compound and at least one tracer compound; an injector configured to deliver the fluid to the patient through a fluid path set; at least one sensor coupled to at least one of the syringe, the injector, or the patient, configured to measure at least one property of the tracer in the fluid, and a feedback path to adjust at least one injection parameter of the injector based on at least one measurement from the at least one sensor.